Novel Mobile Device Application to Improve Adherence

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
Pediatric Heart Transplant RecipientsPediatric Cardiac TransplantationPediatric Heart Transplantation
Interventions
OTHER

Teen Pocket PATH® Mobile Application

Participants in the intervention group will receive the mobile application for improving adherence to their post-transplant medications. The intervention will prompt, remind, and warn participants when medications are due, inform parents when medication management is completed, and engage parents when no action is undertaken.

OTHER

Control Group: Standard of Care

Adolescents and parents/guardians assigned to the Standard Care Condition will receive standard clinical care per standard site procedures.

Trial Locations (8)

10032

Columbia University Medical Center: Pediatric Transplantation, New York

10467

Montefiore Medical Center: Pediatric Transplantation, New York

15224

Children's Hospital of Pittsburgh: Pediatric Transplantation, Pittsburgh

19104

Children's Hospital of Philadelphia: Pediatric Transplantation, Philadelphia

30060

Emory University School of Medicine: Pediatric Transplantation, Atlanta

37232

Monroe Carell Jr. Children's Hospital at Vanderbilt: Pediatric Transplantation, Nashville

63110

St. Louis Children's Hospital: Pediatric Transplantation, St Louis

02115

Boston Children's Hospital: Pediatric Transplantation, Boston

All Listed Sponsors
collaborator

Clinical Trials in Organ Transplantation in Children

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02904278 - Novel Mobile Device Application to Improve Adherence | Biotech Hunter | Biotech Hunter